Safety of a novel microneedle device applied to facial skin: A subject- and rater-blinded, sham-controlled, randomized trial

Archives of Dermatology

Volumn 148, Issue 6, 2012, Pages 711-717

  Hoesly, Fridolin J ^a   Borovicka, Judy ^a   Gordon, Jennifer ^a   Nardone, Beatrice ^a   Holbrook, Jaimee S ^a   Pace, Natalie ^a   Ibrahim, Omer ^a,b   Bolotin, Diana ^a,c   Warycha, Melanie ^a   Kwasny, Mary ^a   West, Dennis ^a   Alam, Murad ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CUTANEOUS PARAMETERS; DERMATOLOGY; DEVICE SAFETY; DEVICES; FACE; FACE SKIN; FEMALE; FINGER PRESSURE; FITZ PATRICK SKIN TYPE; FOREHEAD; HUMAN; MALE; MICRONEEDLE DEVICE; NASOLABIAL FOLD; NEEDLE; PAIN ASSESSMENT; PARALLEL DESIGN; PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SHAM PROCEDURE; SKIN; SKIN EXAMINATION; SKIN PAIN; SKIN REACTION SCORE; TEMPLE; UNIVERSITY;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; AMBULATORY CARE FACILITIES; DOUBLE-BLIND METHOD; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MICROINJECTIONS; MIDDLE AGED; NEEDLES; PHARMACEUTICAL PREPARATIONS; SKIN; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS; YOUNG ADULT;

EID: 84862675010     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2012.280     Document Type: Article

References (17)

1. Prausnitz MR. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev. 2004;56(5):581-587. (Pubitemid 38326934)
2. Tiwary AK, Sapra B, Jain S. Innovations in transdermal drug delivery: formulations and techniques. Recent Pat Drug Deliv Formul. 2007;1(1):23-36.
3. Escobar-Chávez JJ, Bonilla-Martínez D, Villegas- González MA, Molina-Trinidad E, Casas-Alancaster N, Revilla- Vázquez AL. Microneedles: a valuable physical enhancer to increase transdermal drug delivery. J Clin Pharmacol. 2011;51(7): 964-977.
4. Donnelly RF, Morrow DI, McCarron PA, et al. Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy. J Control Release. 2008;129(3):154-162.
5. Mikolajewska P, Donnelly RF, Garland MJ, et al. Microneedle pre-treatment of human skin improves 5-aminolevulininc acid (ALA) - and 5-aminolevulinic acid methyl ester (MAL)-induced PpIX production for topical photodynamic therapy without increase in pain or erythema. Pharm Res. 2010;27(10):2213-2220.
6. Wermeling DP, Banks SL, Hudson DA, et al. Microneedles permit transdermal delivery of a skin-impermeant medication to humans. Proc Natl Acad Sci U S A. 2008;105(6):2058-2063. (Pubitemid 351439464)
7. Coulman SA, Barrow D, Anstey A, et al.Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles. Curr Drug Deliv. 2006; 3(1):65-75.
8. Bal SM, Caussin J, Pavel S, Bouwstra JA. In vivo assessment of safety of microneedle arrays in human skin. Eur J Pharm Sci. 2008;35(3):193-202.
9. Donnelly RF, Raj Singh TR, Woolfson AD. Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv. 2010;17(4):187-207.
10. Kaushik S, Hord AH, Denson DD, et al. Lack of pain associated with microfabricated microneedles. Anesth Analg. 2001;92(2):502-504. (Pubitemid 32127644)
11. Henry S, McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles: a novel approach to transdermal drug delivery. J Pharm Sci. 1998;87(8):922-925. (Pubitemid 28381247)
12. Al-Qallaf B, Das DB. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery. Ann N Y Acad Sci. 2009;1161:83-94.
13. Bal SM, Kruithof AC, Zwier R, et al. Influence of microneedle shape on the transport of a fluorescent dye into human skin in vivo. J Control Release. 2010; 147(2):218-224.
14. Yan G, Warner KS, Zhang J, Sharma S, Gale BK. Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery. Int J Pharm. 2010;391(1-2):7-12.
15. Coulman SA, Birchall JC, Alex A, et al. In vivo, in situ imaging of microneedle insertion into the skin of human volunteers using optical coherence tomography. Pharm Res. 2011;28(1):66-81.
16. Duan D, Moeckly C, Gysbers J, et al. Enhanced delivery of topically-applied formulations following skin pre-treatment with a hand-applied, plastic microneedle array. Curr Drug Deliv. 2011;8(5):557-565.
17. Callender VD, Preston N, Osborn C, Johnson L, Gottschalk RW. A meta-analysis to investigate the relation between Fitzpatrick skin types and tolerability of adapalene- benzoyl peroxide topical gel in subjects with mild or moderate acne. J Clin Aesthet Dermatol. 2010;3(8):15-19.